Left ventricular electromechanical mapping: Preliminary evidence of electromechanical changes after successful coronary intervention

American Heart Journal

Volumn 144, Issue 4, 2002, Pages 693-701

  Perin, Emerson C ^a   Silva, Guilherme V ^a   Sarmento Leite, Rogerio ^a   Vaughn, William K ^a   Fish, R David ^a   Ferguson, James J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC VALUE; ELECTRIC POTENTIAL; ENDOCARDIUM; EPICARDIUM MAPPING; EXCITATION CONTRACTION COUPLING; FEMALE; FUNCTIONAL ANATOMY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MATHEMATICAL ANALYSIS; MICROVASCULATURE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY;

EID: 0036792193     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)00144-8     Document Type: Article

References (44)

1. Labovitz AJ, Lewen MK, Kern M, et al. Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol 1987;10:748-55.
2. Serruys PW, Wijns W, van den Brand M, et al. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation 1984;70:25-36.
3. Heyndrickx GR, Millard RW, McRitchie RJ, et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
4. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
5. Bolli R, Hartley CJ, Rabinovitz RS. Clinical relevance of myocardial "stunning." Cardiovasc Drugs Ther 1991;5:877-90.
6. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
7. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
8. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-51.
9. EPIC Investigation. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty (EPIC). N Engl J Med 1994;330:956-61.
10. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization (EPILOG). N Engl J Med 1997;336:1689-96.
11. CAPTURE Study. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-35.
12. IMPACT-II. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet 1997;349:1422-8.
13. EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade (EPISTENT): evaluation of platelet IIb/IIIa inhibitor for stenting. Lancet 1998;352:82-92.
14. Kornowski R, Hong MK, Lean MB. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation 1998;98:1837-41.
15. Kornowski R, Hong MK, Leon MB. Images in cardiovascular medicine: left ventricular electromechanical mapping of myocardial ischemia. Circulation 1999;99:2708.
16. Kornowski R, Fuchs S, Leon MB. Detection of myocardial viability in the catheterization laboratory using the Biosense-guided electromechanical mapping system. Int J Cardiovasc Intervent 1999;2:125-8.
17. Gepstein L, Goldin A, Lessick J, et al. Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 1998;98:2055-64.
18. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998;98:1116-24.
19. Fuchs S, Kornowski R, Shiran A, et al. Electromechanical characterization of myocardial hibernation in a pig model. Coron Artery Dis 1999;10:195-8.
20. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings (TIMI). N Engl J Med 1985;312:932-6.
21. Gepstein L, Hayam G, Shpun S, et al. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation 1997;96:3672-80.
22. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation 1997;95:1611-22.
23. Smeets JL, Ben-Haim SA, Rodriguez LM, et al. New method for nonfluoroscopic endocardial mapping in humans: accuracy assessment and first clinical results. Circulation 1998;97:2426-32.
24. Van Langenhove G, Hamburger JN, Smits PC, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J 2000;140:596-602.
25. Perin EC, Silva GV, Sarmento-Leite R. Left ventricular electromechanical mapping: a case study of functional assessment in coronary intervention. Tex Heart Inst J 2000;27:253-60.
26. Koch KC, Keck A, Kitzing R, et al. Nonfluoroscopic 3-dimensional catheter-based electroanatomical mapping: follow-up study after successful myocardial revascularization [abstract]. J Am Call Cardiol 1999;33(A Suppl):334A.
27. Koch KC, Stellbrink C, Sasse A, et al. Electromechanical 3D endocardial mapping: follow-up study after successful myocardial revascularization [abstract]. Eur Heart J 1999;20:524.
28. Cleman M, Wohlgelernter D, Cabin H, et al. Myocardial dysfunction during percutaneous transluminal coronary angioplasty. Circulation 1990;81(4 Suppl):14-9.
29. Kitazume H, Kubo I, Iwama T, et al. Left ventricular function during transient coronary occlusion: digital subtraction left ventriculograms during coronary angioplasty. Clin Cardiol 1991;14:665-70.
30. Koolen JJ, Visser CA, David GK, et al. Transesophageal echocardiographic assessment of systolic and diastolic dysfunction during percutaneous transluminal coronary angioplasty. J Am Soc Echocardiogr 1990;3:374-83.
31. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
32. Sakuma T, Hayashi Y, Sumii K, et al. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998;32:890-7.
33. Kondo M, Nakano A, Saito D, et al. Assessment of "microvascular no-reflow phenomenon" using technetium-99m macro-aggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998;32:898-903.
34. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89:2514-8.
35. Morishima I, Sone T, Mokuno S, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995;130:239-43.
36. El-Maraghi N, Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980;62:936-44.
37. Webb JG, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999;34:468-75.
38. Topol E, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-80.
39. Abdelmeguid AE, Whitlow PL, Sapp SK, et al. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation 1995;91:2733-41.
40. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-36.
41. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT Investigators: Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol 1999;33:88-96.
42. Stertzer SH, Pomerantsev EV, Fitzgerald PJ, et al. Effects of technique modification on immediate results of high speed rotational atherectomy in 710 procedures on 656 patients. Cathet Cardiovasc Diagn 1995;36:304-10.
43. Williams MJ, Dow CJ, Newell JB, et al. Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol 1996;28:861-9.
44. Koch KC, vom Dahl J, Kleinhans E. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol 1999;33:998-1004.